摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetra-tert-butyl N--L-γ-glutamyl>-L-glutamate | 32719-57-6

中文名称
——
中文别名
——
英文名称
tetra-tert-butyl N--L-γ-glutamyl>-L-glutamate
英文别名
Cbz-gGlu(OtBu)-gGlu(OtBu)-Glu(OtBu)-OtBu;ditert-butyl (2S)-2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-5-oxo-4-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-oxopentanoyl]amino]pentanedioate
tetra-tert-butyl N-<N-<N-(benzyloxycarbonyl)-L-γ-glutamyl>-L-γ-glutamyl>-L-glutamate化学式
CAS
32719-57-6
化学式
C39H61N3O12
mdl
——
分子量
763.926
InChiKey
LIZWJWFWHSVURK-KCHLEUMXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    76-78 °C
  • 沸点:
    844.9±65.0 °C(Predicted)
  • 密度:
    1.134±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    54
  • 可旋转键数:
    26
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    202
  • 氢给体数:
    3
  • 氢受体数:
    12

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tetra-tert-butyl N--L-γ-glutamyl>-L-glutamate 在 palladium on activated charcoal diethyl cyanophosphoridate 、 氢气三乙胺 作用下, 以 乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 25.0 ℃ 、101.33 kPa 条件下, 反应 5.5h, 生成 N--N-methylamino>-2-thenoyl>-L-γ-glutamyl>-L-γ-glutamyl>-L-glutamic acid trifluoroacetate
    参考文献:
    名称:
    Syntheses and thymidylate synthase inhibitory activity of the poly-.gamma.-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates
    摘要:
    Thirteen poly-gamma-glutamates derived from several novel antifolates have been synthesized by a convergent route. The syntheses of poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (8) (ICI D1694), 2-desamino-N10-propargyl-5,8-dideazafolic acid (6), 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (7), 2-desamino-2-methyl-N10-propargyl-2'-fluoro-5,8-dideazafolic acid (9), and 2-desamino-2-methyl-4-chloro-N10-propargyl-2'-fluoro-3,5,8-trideazafolic acid (11) are described. A key step in the route involves coupling of an alpha-tert-butyl-protected poly-gamma-glutamate of the required chain length to the appropriate 5,8-dideazapteroic acid, obtained by carboxypeptidase G2 cleavage of the parent monoglutamate, if available, or by chemical synthesis. Deprotection with trifluoroacetic acid in the final step gave the desired poly-gamma-glutamyl antifolates as their trifluoroacetate salts. As inhibitors of thymidylate synthase, these polyglutamates were more potent in every case than the corresponding non-polyglutamylated drug.
    DOI:
    10.1021/jm00083a008
  • 作为产物:
    描述:
    Z-谷安酸叔丁基酯 在 palladium on activated charcoal N-甲基吗啉氢气氯甲酸异丁酯 作用下, 以 甲醇 为溶剂, 反应 0.67h, 生成 tetra-tert-butyl N--L-γ-glutamyl>-L-glutamate
    参考文献:
    名称:
    喹唑啉类抗叶酸抑制胸苷酸合酶:N10-炔丙基-5,8-二氮杂壬酸的四种低聚(L-γ-谷氨酰基)缀合物的合成及其酶抑制作用。
    摘要:
    描述了N10-炔丙基-5,8-二氮杂三酸的总共四个,三个,四个和五个L-谷氨酸残基的四个寡(γ-谷氨酰基)缀合物的合成。选择叔丁基作为羧基保护基是为了避免使用碱,从而避免了γ-α转肽的可能性。通过与氯甲酸异丁酯的混合酸酐将起始原料谷氨酸二叔丁基酯与N-(苄氧羰基)-L-谷氨酸α-叔丁酯偶联。产物中的苄氧羰基进行氢解得到羧基保护的二谷氨酸盐,将其用4-[((苄氧羰基)氨基]苯甲酰氯酰化得到保护的氨基苯甲酰胺,或通过使用上述混合的酸酐/氢解顺序进一步循环成三-,四-和五谷氨酸。如上所述,每个姓氏也被酰化,得到苯甲酰胺。通过氢解除去苯甲酰胺中的苄氧羰基,并用炔丙基溴将由此暴露的氨基N-烷基化。用2-氨基-6-(溴甲基)-4-羟基喹唑啉氢溴酸盐进一步烷基化所得炔丙基胺,得到抗叶酸的聚(t-Bu)酯。在最后步骤中,用三氟乙酸脱保护,得到所需的抗叶酸剂,为其三氟乙酸盐。五至谷氨酸二戊酸酯对WI-L2人
    DOI:
    10.1021/jm00121a029
点击查看最新优质反应信息

文献信息

  • Synthesis of the penta-glutamyl derivative of<i>N</i>-[4-[<i>N</i>-[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)-propyl]amino]benzoyl]-L-glutamic acid (5-DACTHF). An acyclic analogue of tetrahydrofolic acid
    作者:Virgil L. Styles、James L. Kelley
    DOI:10.1002/jhet.5570270654
    日期:1990.9
    N-[4-[N-[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl]amino]-benzoyl)-L-glutamic acid (1, 5-DACTHF, 543U76) was synthesized by a convergent route. L-γ-Glutamyl-L-γ-glutamyl-L-γ-glutamyl-L-γ-glutamyl-L-γ-glutamyl-L-glutamic acid heptakis t-butyl ester (20) was prepared in ten steps from L-glutamic acid di-t-butyl ester and N-(benzyloxycarbonyl)-L-glutamic acid α-t-butyl ester. 4-[N-[3-(2,4-Diamino-1
    N- [4- [ N- [3-(2,4-二氨基-1,6-二氢-6-氧代-5-嘧啶基)丙基]氨基]-苯甲酰基)-L-谷氨酸的五谷氨酰基衍生物(1,5-DACTHF,543U76)通过会聚路线合成。L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-谷氨酸庚基叔丁基酯(20)由L-经十个步骤制备谷氨酸二吨丁基酯和ñ - (苄氧羰基)-L-谷氨酸α -叔丁基酯。由嘧啶基丙醛3合成的4- [ N- [3-(2,4-二氨基-1,6-二氢-6-氧代-5-嘧啶基)丙基]三氟乙酰胺基]苯甲酸(6)分三步,与20缩合,然后脱保护得到N- [4- [ N- [3-(2,4-二氨基-1,6-二氢-6-氧代-5-嘧啶基)丙基]氨基]苯甲酰基]-L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-γ-谷氨酰基-L-谷氨酸(2)。六谷氨酸盐2是有效的甘氨酰胺核糖核苷酸转化酶抑制剂。
  • [EN] PROCESSES OF PREPARING POLYGLUTAMATED ANTIFOLATES AND USES OF THEIR COMPOSITIONS<br/>[FR] PROCÉDÉS DE PRÉPARATION D'ANTIFOLATES POLYGLUTAMIQUES ET LEURS UTILISATIONS
    申请人:L E A F HOLDINGS GROUP LLC
    公开号:WO2021026310A1
    公开(公告)日:2021-02-11
    Provided herein are methods of preparing polyglutamated compounds, such as polyglutamated antifolates, and/or pharmaceutical compositions such as liposomal compositions comprising the same, Also provided herein are substantially pure polyglutamated compounds, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition such as liposomal composition comprising the same. The present disclosure further provides methods of using the polyglutamated compounds and compositions to treat diseases including hyperproliferative diseases such as cancer, disorders of the immune system such as rheumatoid arthritis, and infectious diseases such as HIV, malaria, and schistomiasis.
    本文提供了制备多聚谷氨酸化合物的方法,例如多聚谷氨酸化抗叶酸类化合物,以及包含这些化合物的药物组合物,还提供了基本纯净的多聚谷氨酸化合物,或其药用可接受盐,或包含这些化合物的药物组合物。本公开还提供了使用多聚谷氨酸化合物和组合物治疗疾病的方法,包括高增殖性疾病如癌症,免疫系统紊乱如类风湿性关节炎,以及传染病如艾滋病、疟疾和血吸虫病。
  • First use of the Taylor pteridine synthesis as a route to polyglutamate derivatives of antifolates
    作者:Henry Bader、Andre Rosowsky
    DOI:10.1021/jo00010a038
    日期:1991.5
    The di- through penta-gamma-L-glutamates of 2-desamino-2-methylaminopterin, a new antifolate with a novel mechanism of action requiring gamma-polyglutamylation for biological activity, were prepared. alpha-tert-Butyl gamma-methyl L-glutamate was condensed with 4-nitrobenzoyl chloride, the methyl ester selectively hydrolyzed with base, and the product condensed with di-tert-butyl L-glutamate to obtain tri-tert-butyl N-(4-nitrobenzoyl)-gamma-L-glutamyl-L-glutamate. Reduction of the nitro group followed by reaction with 2-amino-5-(chloromethyl)-pyrazine-3-carbonitrile yielded tri-tert-butyl [4-[[(2-amino-3-cyanopyrazin-5-yl)methyl]amino]benzoyl]-L-gamma-glutamyl-L-glutamate, which was heated with acetamidine acetate to form tri-tert-butyl N-[4-[[(4-amino-2-methylpteridine-6-yl)methyl]amino]benzoyl]-gamma-L-glutamyl-L-glutamate. Removal of the ester groups with trifluoroacetic acid then gave 2-desamino-2-methylaminopterin diglutamate. A similar sequence was employed to convert esterified oligomers with three, four, and five glutamyl residues to 2-desamino-2-methylaminopterin tri-, tetra-, and pentaglutamate. This is the first example of the preparation of the polyglutamates of an antifolate via the Taylor pteridine synthesis.
  • STYLES, VIRGIL L.;KELLEY, JAMES L., J. HETEROCYCL. CHEM., 27,(1990) N, C. 1809-1813
    作者:STYLES, VIRGIL L.、KELLEY, JAMES L.
    DOI:——
    日期:——
  • Quinazoline antifolates inhibiting thymidylate synthase: synthesis of four oligo(L-.gamma.-glutamyl) conjugates of N10-propargyl-5,8-dideazafolic acid and their enzyme inhibition
    作者:Krzysztof Pawelczak、Terence R. Jones、Michal Kempny、Ann L. Jackman、David R. Newell、Leszek Krzyzanowski、Barbara Rzeszotarska
    DOI:10.1021/jm00121a029
    日期:1989.1
    benzyloxycarbonyl group in the product gave a carboxyl-protected diglutamate, which either was acylated with 4-[(benzyloxycarbonyl)amino] benzoyl chloride to give a protected aminobenzamide or was cycled further by using the above mixed anhydride/hydrogenolysis sequence into tri-, tetra-, and pentaglutamates. Each of the last named was also acylated, as above, to give a benzamide. The benzyloxycarbonyl group in the
    描述了N10-炔丙基-5,8-二氮杂三酸的总共四个,三个,四个和五个L-谷氨酸残基的四个寡(γ-谷氨酰基)缀合物的合成。选择叔丁基作为羧基保护基是为了避免使用碱,从而避免了γ-α转肽的可能性。通过与氯甲酸异丁酯的混合酸酐将起始原料谷氨酸二叔丁基酯与N-(苄氧羰基)-L-谷氨酸α-叔丁酯偶联。产物中的苄氧羰基进行氢解得到羧基保护的二谷氨酸盐,将其用4-[((苄氧羰基)氨基]苯甲酰氯酰化得到保护的氨基苯甲酰胺,或通过使用上述混合的酸酐/氢解顺序进一步循环成三-,四-和五谷氨酸。如上所述,每个姓氏也被酰化,得到苯甲酰胺。通过氢解除去苯甲酰胺中的苄氧羰基,并用炔丙基溴将由此暴露的氨基N-烷基化。用2-氨基-6-(溴甲基)-4-羟基喹唑啉氢溴酸盐进一步烷基化所得炔丙基胺,得到抗叶酸的聚(t-Bu)酯。在最后步骤中,用三氟乙酸脱保护,得到所需的抗叶酸剂,为其三氟乙酸盐。五至谷氨酸二戊酸酯对WI-L2人
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物